Randomized Trial of Adjuvant Curcumin After Prostatectomy
yair lotan
Summary
This is a prospective study to determine if the adjuvant use of Curcumin improves recurrence-free survival.
Description
This is a prospective study to determine if the adjuvant use of Curcumin improves recurrence-free survival in patients after radical prostatectomy compared to placebo
Eligibility
- Age range
- 30–80 years
- Sex
- Male
- Healthy volunteers
- No
Inclusion Criteria: * Status post radical prostatectomy for histologically confirmed adenocarcinoma of the prostate * pathologically confirmed T1-T3 disease * no sign of lymph node or metastatic disease * pT1-pT3pNxMx patients in whom standard NCCN or AUA guidelines would suggest are at low risk for pelvic lymph node or metastatic disease and who would not require confirmatory imaging for metastatic disease. This includes patients with Gleason 6 or 7(T2 disease) and PSA less than 20. * Eastern Cooperative Oncology Group(ECOG) status 0-2 * adequate renal and liver function as well as bone marr…
Interventions
- DrugCurcumin
Curcumin or placebo 500mg by mouth twice a day for 6 months
- Drugplacebo
placebo orally twice a day
Location
- UT Southwestern Medical CenterDallas, Texas